The causative agent of African sleeping sickness, Trypanosoma brucei, undergoes an unusual mitochondrial
RNA editing process that is essential for its survival. RNA editing
terminal uridylyl transferase 2 of T. brucei (TbRET2) is an indispensable component of the editosome machinery
that performs this editing. TbRET2 is required to maintain the vitality
of both the insect and bloodstream forms of the parasite, and with
its high-resolution crystal structure, it poses as a promising pharmaceutical
target. Neither the exclusive requirement of uridine 5'-triphosphate
(UTP) for catalysis, nor the RNA primer preference of TbRET2 is well-understood.
Using all-atom explicitly solvated molecular dynamics (MD) simulations,
we investigated the effect of UTP binding on TbRET2 structure and
dynamics, as well as the determinants governing TbRET2’s exclusive
UTP preference. Through our investigations of various nucleoside triphosphate
substrates (NTPs), we show that UTP preorganizes the binding site
through an extensive water-mediated H-bonding network, bringing Glu424
and Arg144 side chains to an optimum position for RNA primer binding.
In contrast, cytosine 5'-triphosphate (CTP) and adenosine 5'-triphosphate
(ATP) cannot achieve this preorganization and thus preclude productive
RNA primer binding. Additionally, we have located ligand-binding “hot
spots” of TbRET2 based on the MD conformational ensembles and
computational fragment mapping. TbRET2 reveals different binding pockets
in the apo and UTP-bound MD simulations, which could be targeted for
inhibitor design.